Intracranial haemorrhages associated with oral anticoagulant therapy. Analysis of 38 cases;Hémorragies intracrâniennes associées à un traitement anticoagulant oral: Analyse de 38 observations

Therapie

Volumn 57, Issue 3, 2002, Pages 297-301

  Gras Champel, V ^a   Pannier, M ^a   Tellier, V ^a   Voyer, A ^a   Roussel, B ^a   Masson, H ^a   Jeanjean, P ^a   Montpellier, D ^a   Canaple, S ^a   Toussaint, P ^a   Andrejak M ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

Anticoagulant therapy; Haemorrhagia; Iatrogenicity; Pharmacovigilance

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; ALLOPURINOL; AMIODARONE; ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN; THYROID HORMONE;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; DEATH; FEMALE; FRANCE; HEADACHE; HUMAN; HYPERTENSION; INTERNATIONAL STANDARD UNIT; MALE; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; CEREBRAL HEMORRHAGE; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 0036588283     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Drouet L, Fiessinger JN, Boneu B, et al. Mobilisation pour les antivitamines K. Sang Thrombose Vaisseaux 2000; 12: 347-399
2. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996; 348: 423-428
3. Pouyanne P, Haramburu F, Imbs JL, et al. Admissions to hospital caused by adverse drug reactions cross sectional incidence study. BMJ 2000; 320: 1036
4. White RH, McKittrick T, Takakuwa, et al. Management and prognosis of life-threatening bleeding during warfarin therapy. Arch Intern Med 1996; 156: 1197-1201
5. Butler AC, Tait RC. Management of oral anticoagulant-induced intracranial haemorrhage. Blood reviews 1998; 12: 35-44
6. Hylek EM, Singer DE. Risk factors for intracranial hemorrhage in outpatients taking warfarin. Ann Intern Med 1994; 120: 897-902
7. Bégaud B, Evreux JC, Jouglard J, et al. Imputabilité des effets inattendus ou toxiques des médicaments. Thérapie 1985; 40: 111-118
8. Van der Meer FJM, Frit SR, Vandenbroucke JP, et al. Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. Arch Intern Med 1993; 153: 1557-1562
9. Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly. Arch Intern Med 2000; 160: 470-478
10. Fihn SD, Callahan CM, Martin DC, et al. The risk for and severity of bleeding complications in elderly patients treated with warfarin. Ann Intern Med 1996; 124: 970-979
11. Berwaerts J, Webster J. Analysis of risk factors involved in oral anticoagulant-related intracranial haemorrhages. Q J Med 2000; 93: 513-521
12. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998; 105: 91-99
13. Zodpey SP, Tiwari RR, Kulkarni HR. Risk factors for haemorrhagic stroke: a case-control study. Public Health 2000; 114: 177-182
14. Anticoagulant in the secondary prevention of events in coronary thrombosis (ASPECT) Research Group. Effect of long-term anticoagulant treatment on mortality and cardiovascular morbidity after myocardial infarction. Lancet 1994; 343: 499-503
15. Landefeld CS, Goldman L. Major bleeding in outpatients treated with warfarin: incidence and prediction by factors known at the start of outpatients therapy. Am J Med 1989; 87: 144-151
16. Hart RG, Bradley SB, Anderson DC. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke 1995; 26: 1471-1477
17. Hylek EM, Chang YC, Skates SJ, et al. Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation. Arch Intern Med 2000; 160: 1612-1617
18. Samsa GP, Matchar DB, Goldstein LB, et al. Quality of anticoagulation management among patients with atrial fibrillation. Arch Intern Med 2000; 160: 967-973
19. th Edition. Elsevier Science B.V. 2000: 1171-207